Correlations between cognitive impairment and brain-derived neurotrophic factor expression in the hippocampus of post-stroke depression rats

Molecular Medicine Reports

Volumn 6, Issue 4, 2012, Pages 889-893

  Zhang, Zhao Hui ^a   Wu, Li Na ^a   Song, Jing Gui ^a   Li, Wen Qiang ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor; Cognitive function; Hippocampus; Post stroke depression

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; ISOLATION PROCEDURE; LEARNING; MALE; MEMORY; MIDDLE CEREBRAL ARTERY; NONHUMAN; PASSIVE AVOIDANCE; POSTSTROKE DEPRESSION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STRESS;

ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION DISORDERS; DEPRESSION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; STROKE;

EID: 84865188466     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1009     Document Type: Article

References (25)

1. Haq SU, Symeon C, Agius M and Brady R: Screening for depression in post stroke patients. Psychiatr Danub 22: 33-35, 2010.
2. Mihara T, Mihara K, Yarimizu J, et al: Pharmacological characterization of a novel, potent adenosine A1 and A2 receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H) -one(ASP5854), in models of Parkinson's disease and cognition. J Pharmacol Exp Ther 323: 708-719, 2007. (Pubitemid 350005141)
3. Barba R, Martínez-Espinosa S, Rodríguez-García E, Pondal M, Vivancos J and Del Ser T: Post-stroke dementia: clinical features and risk factors. Stroke 31: 1494-1501, 2000. (Pubitemid 30437493)
4. Erickson KI, Prakash RS, Voss MW, et al: Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 30: 5368-5375, 2010.
5. Li G, Peskind ER, Millard SP, et al: Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 4: e5424, 2009.
6. O'Bryant SE, Hobson VL, Hall JR, et al: Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dement Geriatr Cogn Disord 31: 31-6, 2011.
7. von Bohlen und Halbach O: Involvement of BDNF in age-dependent alterations in the hippocampus. Front Aging Neurosci 13: 2, 2010.
8. Zhou Z, Lu T, Xu G, et al: Decreased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism. Clin Chem Lab Med 49: 185-189, 2011.
9. Yang L, Zhang Z, Sun D, et al: Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. Int J Geriatr Psychiatry 26: 495-502, 2011.
10. Teixeira AL, Barbosa IG, Diniz BS and Kummer A: Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomark Med 4: 871-887, 2010.
11. Murer M, Yan Q and Raisman-Vozari R: Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63: 71-124, 2001.
12. McAllister AK: Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci 58: 1054-1060, 2001.
13. Mertz K, Koscheck T and Schilling K: Brain-derived neurotrophic factor modulates dendritic morphology of cerebellar basket and stellate cells: an in vitro study. Neuroscience 97: 303-310, 2000. (Pubitemid 30224768)
14. Ohira K and Hayashi M: A new aspect of the TrkB signaling pathway in neural plasticity. Curr Neuropharmacol 7: 276-285, 2009.
15. Yoshii A and Constantine-Paton M: Post-synaptic BDNF-TrkB signaling in synapse maturation, plasticity and disease. Dev Neurobiol 70: 304-322, 2010.
16. Figurov A, Pozzo-Miller LD, Olafsson P, Wang T and Lu B: Regulation of synaptic responses to high frequency stimulation and LTP by neurotrophins in the hippocampus. Nature 381: 706-709, 1996. (Pubitemid 26196571)
17. Cunha C, Brambilla R and Thomas KL: A simple role for BDNF in learning and memory? Front Mol Neurosci 3: 1, 2010.
18. Angelucci F, Mathé AA and Aloe L: Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res 146: 151-165, 2004. (Pubitemid 37541382)
19. Almeida RD, Manadas BJ, Melo CV, et al: Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 12: 1329-1343, 2005. (Pubitemid 41486103)
20. Harper MM, Adamson L, Blits B, Bunge MB, Grozdanic SD and Sakaguchi DS: Brain-derived neurotrophic factor released from engineered mesenchymal stem cells attenuates glutamate- and hydrogen peroxide-mediated death of staurosporine-differentiated RGC-5 cells. Exp Eye Res 89: 538-548, 2009.
21. Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91, 1989. (Pubitemid 19040218)
22. Xu J, Zhang QG, Li C and Zhang GY: Subtoxic N-methyl-D-aspartate delayed neuronal death in ischemic brain injury through TrkB receptor- and calmodulin-mediated PI-3K/Akt pathway activation. Hippocampus 14:525-537, 2007. (Pubitemid 47068262)
23. Tata DA, Marciano VA and Anderson BJ: Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J Comp Neurol 498: 363-374, 2006. (Pubitemid 44205080)
24. Jacobsen JP and Mørk A: Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat. Brain Res 110: 221-225, 2006. (Pubitemid 44344611)
25. Numakawa T, Kumamaru E, Adachi N, Yagasaki Y, Izumi A and Kunugi H: Glucocorticoid receptor interaction with TrkB promotes BDNF-triggered PLC-gamma signaling for glutamate release via a glutamate transporter. Proc Natl Acad Sci USA 106: 647-652, 2009.